Your browser doesn't support javascript.
loading
Risk of breast cancer with HRT depends on therapy type and duration.
Saul, Helen; Gursul, Deniz; Cassidy, Samantha; Vinogradova, Yana.
Affiliation
  • Saul H; NIHR Centre for Engagement and Dissemination, Twickenham, UK.
  • Gursul D; NIHR Centre for Engagement and Dissemination, Twickenham, UK.
  • Cassidy S; NIHR Centre for Engagement and Dissemination, Twickenham, UK.
  • Vinogradova Y; University of Nottingham, UK.
BMJ ; 376: o485, 2022 03 08.
Article in En | MEDLINE | ID: mdl-35260385
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Progestins / Breast Neoplasms / Estrogen Replacement Therapy / Estrogens Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: BMJ Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Progestins / Breast Neoplasms / Estrogen Replacement Therapy / Estrogens Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: BMJ Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido